Crossref
Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis
Modern Rheumatology · 04.11.2026 · 36 (6) · 1066-1066
DOI: 10.1093/mr/roag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 25.08.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis. Modern Rheumatology, 36(6), 1066-1066. https://doi.org/10.1093/mr/roag060
Vancouver
Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis. Modern Rheumatology. 2026;36(6):1066-1066. doi:10.1093/mr/roag060
BibTeX
@article{euvimed2026,
title = {Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis},
journal = {Modern Rheumatology},
year = {2026},
volume = {36},
number = {6},
pages = {1066--1066},
doi = {10.1093/mr/roag060}
}
EUVIMED